Rates of perinatal environment risk factors in schizophrenia patients with higher and lower schizophrenia polygenic risk scores

被引：0
|
作者：
Alfimova, M. [1 ]
Gabaeva, M. [1 ]
Lezheiko, T. [1 ]
Plakunova, V. [1 ]
Golimbet, V. [1 ]
机构：
[1] Mental Hlth Res Ctr, Clin Genet Lab, Moscow, Russia
来源：
EUROPEAN PSYCHIATRY | 2024年 / 67卷
基金：
俄罗斯科学基金会;
关键词：
D O I：
10.1192/j.eurpsy.2024.611
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPP0468
引用
收藏
页码：S293 / S294
页数：2
相关论文
共 50 条
  • [31] Relationship between polygenic risk scores and symptom dimensions of schizophrenia and schizotypy in multiplex families with schizophrenia
    Ahangari, Mohammad
    Bustamante, Daniel
    Kirkpatrick, Robert
    Nguyen, Tan-Hoang
    Verrelli, Brian C.
    Fanous, Ayman
    Kendler, Kenneth S.
    Webb, Bradley T.
    Bacanu, Silviu-Alin
    Riley, Brien P.
    BRITISH JOURNAL OF PSYCHIATRY, 2023, 223 (01) : 301 - 308
  • [32] Influence of polygenic risk scores for schizophrenia and resilience on the cognition of individuals at-risk for psychosis
    He, Qin
    Mam-Lam-Fook, Celia Jantac
    Chaignaud, Julie
    Danset-Alexandre, Charlotte
    Iftimovici, Anton
    Hauguel, Johanna Gradels
    Houle, Gabrielle
    Liao, Calwing
    Dion, Patrick A.
    Rouleau, Guy A.
    Kebir, Oussama
    Krebs, Marie-Odile
    Chaumette, Boris
    TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
  • [33] Polygenic risk scores differentiate schizophrenia patients with toxoplasma gondii compared to toxoplasma seronegative patients
    Lori, Adriana
    Avramopoulos, Dimitrios
    Wang, Alex W.
    Mulle, Jennifer
    Massa, Nicholas
    Duncan, Erica J.
    Powers, Abigail
    Conneely, Karen
    Gillespie, Charles F.
    Jovanovic, Tanja
    Ressler, Kerry J.
    Pearce, Brad D.
    COMPREHENSIVE PSYCHIATRY, 2021, 107
  • [34] Influence of polygenic risk scores for schizophrenia and resilience on the cognition of individuals at-risk for psychosis
    Qin He
    Célia Jantac Mam-Lam-Fook
    Julie Chaignaud
    Charlotte Danset-Alexandre
    Anton Iftimovici
    Johanna Gradels Hauguel
    Gabrielle Houle
    Calwing Liao
    Patrick A. Dion
    Guy A. Rouleau
    Oussama Kebir
    Marie-Odile Krebs
    Boris Chaumette
    Translational Psychiatry, 11
  • [35] POLYGENIC RISK SCORES IN SCHIZOPHRENIA WITH CLINICALLY SIGNIFICANT COPY NUMBER VARIANTS
    Taniguchi, Satoru
    Ninomiya, Kohei
    Kushima, Itaru
    Okochi, Tomo
    Saito, Takeo
    Shimasaki, Ayu
    Sakusabe, Takaya
    Momozawa, Yukihide
    Kubo, Michiaki
    Kamatani, Yoichiro
    Ozaki, Norio
    Ikeda, Masashi
    Iwata, Nakao
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S212 - S212
  • [36] Polygenic risk scores do not add value for predicting schizophrenia outcomes
    Zarate, Jean Mary
    NATURE NEUROSCIENCE, 2021, 24 (11) : 1503 - 1503
  • [37] Polygenic risk scores do not add value for predicting schizophrenia outcomes
    Shari Wiseman
    Nature Neuroscience, 2021, 24 : 1503 - 1503
  • [38] Independent component analysis of SNPs reflects polygenic risk scores for schizophrenia
    Chen, Jiayu
    Calhoun, Vince D.
    Pearlson, Godfrey D.
    Perrone-Bizzozero, Nora I.
    Turner, Jessica A.
    Ehrlich, Stefan
    Ho, Beng-Choon
    Liu, Jingyu
    SCHIZOPHRENIA RESEARCH, 2017, 181 : 83 - 85
  • [39] Polygenic risk scores in schizophrenia with clinically significant copy number variants
    Taniguchi, Satoru
    Ninomiya, Kohei
    Kushima, Itaru
    Saito, Takeo
    Shimasaki, Ayu
    Sakusabe, Takaya
    Momozawa, Yukihide
    Kubo, Michiaki
    Kamatani, Yoichiro
    Ozaki, Norio
    Ikeda, Masashi
    Iwata, Nakao
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2020, 74 (01) : 35 - 39
  • [40] Polygenic Risk Scores Differentiating Schizophrenia From Bipolar Disorder Are Associated With Premorbid Intelligence in Schizophrenia Patients and Healthy Subjects
    Ohi, Kazutaka
    Nishizawa, Daisuke
    Sugiyama, Shunsuke
    Takai, Kentaro
    Kuramitsu, Ayumi
    Hasegawa, Junko
    Soda, Midori
    Kitaichi, Kiyoyuki
    Hashimoto, Ryota
    Ikeda, Kazutaka
    Shioiri, Toshiki
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021, 24 (07): : 562 - 569
12345